_version_ 1784729810942033920
author Laribi, Kamel
Baugier de Materre, Alix
Ghez, David
Dartigeas, Caroline
Tomowiak, Cécile
Mahé, Béatrice
Micol, Jean-Baptiste
Merabet, Fatiha
Leprêtre, Stéphane
Herbaux, Charles
Ysebaert, Loïc
Le Calloch, Ronan
Willems, Lise
Voldoire, Maud
Roos-Weil, Damien
Bravetti, Clotilde
Touileb, Yamina
Davi, Frédéric
Nguyen-Khac, Florence
Maloum, Karim
Béné, Marie C.
author_facet Laribi, Kamel
Baugier de Materre, Alix
Ghez, David
Dartigeas, Caroline
Tomowiak, Cécile
Mahé, Béatrice
Micol, Jean-Baptiste
Merabet, Fatiha
Leprêtre, Stéphane
Herbaux, Charles
Ysebaert, Loïc
Le Calloch, Ronan
Willems, Lise
Voldoire, Maud
Roos-Weil, Damien
Bravetti, Clotilde
Touileb, Yamina
Davi, Frédéric
Nguyen-Khac, Florence
Maloum, Karim
Béné, Marie C.
author_sort Laribi, Kamel
collection PubMed
description
format Online
Article
Text
id pubmed-9208889
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92088892022-06-22 Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy Laribi, Kamel Baugier de Materre, Alix Ghez, David Dartigeas, Caroline Tomowiak, Cécile Mahé, Béatrice Micol, Jean-Baptiste Merabet, Fatiha Leprêtre, Stéphane Herbaux, Charles Ysebaert, Loïc Le Calloch, Ronan Willems, Lise Voldoire, Maud Roos-Weil, Damien Bravetti, Clotilde Touileb, Yamina Davi, Frédéric Nguyen-Khac, Florence Maloum, Karim Béné, Marie C. Hemasphere Letter Lippincott Williams & Wilkins 2022-05-11 /pmc/articles/PMC9208889/ /pubmed/35747848 http://dx.doi.org/10.1097/HS9.0000000000000716 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter
Laribi, Kamel
Baugier de Materre, Alix
Ghez, David
Dartigeas, Caroline
Tomowiak, Cécile
Mahé, Béatrice
Micol, Jean-Baptiste
Merabet, Fatiha
Leprêtre, Stéphane
Herbaux, Charles
Ysebaert, Loïc
Le Calloch, Ronan
Willems, Lise
Voldoire, Maud
Roos-Weil, Damien
Bravetti, Clotilde
Touileb, Yamina
Davi, Frédéric
Nguyen-Khac, Florence
Maloum, Karim
Béné, Marie C.
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title_full Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title_fullStr Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title_full_unstemmed Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title_short Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
title_sort therapy-related myeloid neoplasms in patients with chronic lymphocytic leukemia who received fcr/fc as frontline therapy
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208889/
https://www.ncbi.nlm.nih.gov/pubmed/35747848
http://dx.doi.org/10.1097/HS9.0000000000000716
work_keys_str_mv AT laribikamel therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT baugierdematerrealix therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT ghezdavid therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT dartigeascaroline therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT tomowiakcecile therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT mahebeatrice therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT micoljeanbaptiste therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT merabetfatiha therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT lepretrestephane therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT herbauxcharles therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT ysebaertloic therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT lecallochronan therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT willemslise therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT voldoiremaud therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT roosweildamien therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT bravetticlotilde therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT touilebyamina therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT davifrederic therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT nguyenkhacflorence therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT maloumkarim therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy
AT benemariec therapyrelatedmyeloidneoplasmsinpatientswithchroniclymphocyticleukemiawhoreceivedfcrfcasfrontlinetherapy